The drug-resistant and deadly fungus Candida auris has proven difficult to eradicate in 2026, according to new data from the Centers for Disease Control and Prevention (CDC).

First reported in the U.S. in 2016, Candida auris has rapidly spread over the past several years. Some strains are classified as a superbug due to their resistance to all common antifungal medications.

While healthy individuals may fend off the infection, it poses a serious threat in healthcare settings where patients are often vulnerable. The fungus can survive on surfaces for extended periods and spreads through medical devices such as catheters, breathing tubes, or IVs.

As of mid-2026, nearly half of U.S. states have reported cases to the CDC, with 23 states confirming the presence of the superbug. Texas leads with over 700 known cases, followed by Michigan with 503 cases. A review of infections between 2022 and 2024 found that approximately 88% of clinical cases occurred in people over the age of 45.

Despite ongoing containment efforts, Candida auris remains a significant public health challenge.

Sources